Advertisement
Screener

Syndax Pharmaceuticals, Inc. (SNDX) ROA

Syndax Pharmaceuticals, Inc. (SNDX) ROA

  • 2026-06-30: ROA -31.37%.
  • 2026-03-31: ROA -51.46%.
  • 2025-12-31: ROA -53.88%.
  • 2025-09-30: ROA -56.47%.

Complete source-backed roa history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-31.37%
2026-03-31-51.46%
2025-12-31-53.88%
2025-09-30-56.47%
2025-06-30-56.19%
2025-03-31-51.69%
2024-12-31-43.98%
2024-09-30-69.76%
2024-06-30-55.37%
2024-03-31-44.31%
2023-12-31-34.16%
2023-09-30-44.11%
2023-06-30-37.17%
2023-03-31-33.34%
2022-12-31-30.03%
2022-09-30-3.88%
2022-06-300.20%
2022-03-313.67%
2021-12-315.54%
2021-09-30-38.29%
2021-06-30-34.78%
2021-03-31-30.62%
2020-12-31-24.34%
2020-09-30-37.22%
2020-06-30-30.69%
2020-03-31-54.19%
2019-12-31-88.23%
2019-09-30-79.71%
2019-06-30-74.83%
2019-03-31-69.29%
2018-12-31-88.11%
2018-09-30-76.95%
2018-06-30-68.31%
2018-03-31-56.04%
2017-12-31-44.32%
2017-09-30-42.18%
2017-06-30-38.91%
2017-03-31-48.24%
2016-12-31-40.80%
2016-09-30-33.06%
2016-06-30-24.78%
2016-03-31-21.68%
2015-12-31-26.83%

Annual ROA

DateROA
2025-12-31-53.88%
2024-12-31-43.98%
2023-12-31-34.16%
2022-12-31-30.03%
2021-12-315.54%
2020-12-31-24.34%
2019-12-31-88.23%
2018-12-31-88.11%
2017-12-31-44.32%
2016-12-31-40.80%
2015-12-31-26.83%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Innoviva, Inc. (INVA)United States$1.493B4.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50